Leigh Baldwin & Co’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$361K Buy
3,937
+6
+0.2% +$525 0.19% 114
2026
Q1
$335K Sell
3,931
-500
-11% -$44.6K 0.22% 113
2025
Q4
$350K Sell
4,431
-500
-10% -$39.2K 0.23% 103
2025
Q3
$394K Buy
4,931
+275
+6% +$23.5K 0.22% 109
2025
Q2
$423K Buy
4,656
+14
+0.3% +$1.28K 0.28% 91
2025
Q1
$435K Hold
4,642
– – 0.35% 79
2024
Q4
$422K Buy
+4,642
New +$443K 0.36% 82

Other funds holding CL

Leigh Baldwin & Co's CL Position: Q2 2026 in Review

Leigh Baldwin & Co increased its Colgate-Palmolive (CL) stake by 0.15% in Q2 2026, buying an estimated $525 and bringing the position to 3,937 shares worth $361K. The position accounts for 0.19% of the portfolio, ranked #114.

Leigh Baldwin & Co first reported a position in CL in Q4 2024 and has held it in 7 quarters since. The position peaked at $435K in Q1 2025. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Leigh Baldwin & Co held 3,937 shares of Colgate-Palmolive worth $361K as of Q2 2026.
  • Leigh Baldwin & Co bought 6 Colgate-Palmolive shares in Q2 2026, an estimated $525.
  • Colgate-Palmolive made up 0.19% of Leigh Baldwin & Co's portfolio in Q2 2026, its #114 holding.
  • Leigh Baldwin & Co first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
  • Leigh Baldwin & Co's Colgate-Palmolive position peaked at $435K in Q1 2025.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Leigh Baldwin & Co's 13F filing for Q2 2026, filed 13 Aug 2026.